Patent Applications published on Nov 18, 2010 - page 12

#3301 ✅ Patent 8,372,162 granted on 2013-02-12
US20100290976A1
Chemistry; metallurgy

Method of producing sodium carbonate decahydrate

#3302
US20100290977A1
Performing operations; transporting

METHOD OF REMOVING HYDROCARBON IMPURITIES FROM A GAS

#3303 ✅ Patent 8,512,663 granted on 2013-08-20
US20100290978A1
Performing operations; transporting

Pyrolysis reactor materials and methods

#3304 ✅ Patent 7,998,449 granted on 2011-08-16
US20100290979A1
Mechanical engineering

Carbon nanotubes production process

#3305
US20100290980A1
Chemistry; metallurgy

FLUORINE EXTRACTION SYSTEMS AND ASSOCIATED PROCESSES

#3306
US20100290981A1
Performing operations; transporting

MONOLITHIC CATALYST AND USES THEREOF

#3307
US20100290982A1
Human necessities

SOLID IN OIL/WATER EMULSION-DIFFUSION-EVAPORATION FORMULATION FOR PREPARING CURCUMIN-LOADED PLGA NANOPARTICLES

#3308 ✅ Patent 10,952,965 granted on 2021-03-23
US20100290983A1
Human necessities

Compositions and methods for drug delivery

#3309 ✅ Patent 8,835,608 granted on 2014-09-16
US20100290984A1
Chemistry; metallurgy

Anti-MRP3 antibodies and methods of use

#3310 ✅ Patent 8,753,610 granted on 2014-06-17
US20100290985A1
Chemistry; metallurgy

Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions

#3311 ✅ Patent 9,149,481 granted on 2015-10-06
US20100290986A1
Human necessities

Therapeutic use of diaminophenothiazines

#3312 ✅ Patent 8,524,444 granted on 2013-09-03
US20100290987A1
Chemistry; metallurgy

Methods and compositions for detections and modulating O-glycosylation

#3313 ✅ Patent 8,293,208 granted on 2012-10-23
US20100290988A1
Human necessities

Fluorinated fructose derivatives for PET imaging

#3314
US20100290989A1
Human necessities

COMPOSITIONS AFFECTING HYALURONIC ACID MEDIATED ACTIVITY

#3315
US20100290990A1
Human necessities

METHOD FOR PREPARING A MARKED PURINE DERIVATIVE, SAID DERIVATIVE AND USES THEREOF

#3316
US20100290991A1
Human necessities

NOVEL [F-18]-LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), THEIR USE AND PROCESSES FOR THEIR PREPARATION

#3317
US20100290992A1
Chemistry; metallurgy

NANOPARTICLE NUCLEIC ACID BINDING COMPOUND CONJUGATES FORMING I-MOTIFS

#3318
US20100290993A1
Chemistry; metallurgy

Antibodies to IL-6 and use thereof

#3319 ✅ Patent 8,569,332 granted on 2013-10-29
US20100290994A1
Physics

O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders

#3320 ✅ Patent 8,273,327 granted on 2012-09-25
US20100290995A1
Human necessities

Radio-opaque compounds, compositions containing same and methods of their synthesis and use

#3321
US20100290996A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS BASED ON CULTURING MICROORGANISMS IN LOW SEDIMENTAL FLUID SHEAR CONDITIONS

#3322
US20100290997A1
Human necessities

Imaging Agents and Methods

#3323 ✅ Patent 8,980,223 granted on 2015-03-17
US20100290998A1
Human necessities

Methods of preventing ischemic injury using peripheral nociceptive stimulation

#3324 ✅ Patent 8,367,042 granted on 2013-02-05
US20100290999A1
Human necessities

Nanoparticles of light emissive polymers and preparation method thereof

#3325
US20100291000A1
Human necessities

Diagnostic value of systemic ACE pathway activation in the detection by fluorescence of localized pathological lesions

#3326
US20100291001A1
Chemistry; metallurgy

METALLOPROTEINASE-BINDING PROTEINS

#3327 ✅ Patent 8,795,705 granted on 2014-08-05
US20100291002A1
Human necessities

Dermatologic compositions comprising pyrrolidone-5-carboxylic acid and at least one entity chosen from citrulline, arginine and asparagine, and uses thereof in the treatment of atopic dermatitis

#3328 ✅ Patent 8,450,525 granted on 2013-05-28
US20100291003A1
Chemistry; metallurgy

Histone deacetylase inhibitors

#3329
US20100291004A1
Human necessities

COMPOSITIONS FOR DELIVERING HYPNOTIC AGENTS ACROSS THE ORAL MUCOSA AND METHODS OF USE THEREOF

#3330 ✅ Patent 8,063,107 granted on 2011-11-22
US20100291005A1
Human necessities

Use of trans-pellitorin as flavor substance

#3331
US20100291006A1
Human necessities

Natural Preservatives and Antimicrobial Agents

#3332
US20100291007A1
Human necessities

Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase

#3333
US20100291008A1
Human necessities

EMULSION COMPOSITION

#3334
US20100291009A1
Human necessities

PREPARATION COMPRISING CHROMAN-2-ONE DERIVATIVES

#3335
US20100291010A1
Chemistry; metallurgy

NOVEL ESTERS AND COMPOSITIONS AND USES THEREOF

#3336
US20100291011A1
Human necessities

Water-In-Oil Emulsion Type Sunscreen Cosmetic

#3337
US20100291012A1
Human necessities

ADMINISTRATION OF AMOROLFINE BY IONTOPHORESIS FOR TREATING NAIL DISEASES

#3338
US20100291013A1
Human necessities

COMFORTABLE, TRANSFER-RESISTANT COLORED COMPOSITIONS

#3339 ✅ Patent 10,639,247 granted on 2020-05-05
US20100291014A1
Human necessities

Pigment mixtures

#3340
US20100291015A1
Human necessities

METHOD FOR MAKING UP THE LIPS

#3341 ✅ Patent 8,178,732 granted on 2012-05-15
US20100291016A1
Chemistry; metallurgy

Perfuming ingredients imparting sap and/or earthy type notes

#3342
US20100291017A1
Human necessities

Hair Treatment Compositions

#3343
US20100291018A1
Human necessities

CONDITIONER FOR EYELASH AND EYEBROW

#3344 ✅ Patent 8,394,364 granted on 2013-03-12
US20100291019A1
Human necessities

Methods of using ophthalmic compositions comprising povidone-iodine

#3345 ✅ Patent 8,338,450 granted on 2012-12-25
US20100291020A1
Chemistry; metallurgy

Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors

#3346 ✅ Patent 8,980,242 granted on 2015-03-17
US20100291021A1
Human necessities

Aliphatic prodrug linker

#3347
US20100291022A1
Human necessities

Fly Gel Bait

#3348
US20100291023A1
Chemistry; metallurgy

METHOD FOR EXTENDING THE HALF-LIFE OF EXOGENOUS OR ENDOGENOUS SOLUBLE MOLECULES

#3349
US20100291024A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES

#3350
US20100291025A1
Chemistry; metallurgy

INDAZOLE INHIBITORS OF TYROSINE KINASE

#3351 ✅ Patent 8,299,084 granted on 2012-10-30
US20100291026A1
Chemistry; metallurgy

Piperidine inhibitors of Janus kinase 3

#3352
US20100291027A1
Human necessities

HYALURONIC ACID (HA) INJECTION VEHICLE

#3353 ✅ Patent 9,566,313 granted on 2017-02-14
US20100291028A1
Human necessities

Method of treating peripheral vascular diseases using IL-18 inhibitors

#3354
US20100291029A1
Chemistry; metallurgy

METHODS OF USING IL-21

#3355 ✅ Patent 8,361,954 granted on 2013-01-29
US20100291030A1
Human necessities

Use of IL-28 and IL-29 to treat cancer and autoimmune disorders

#3356 ✅ Patent 8,802,840 granted on 2014-08-12
US20100291031A2
Chemistry; metallurgy

Bicyclic nucleosides and nucleotides as therapeutic agents

#3357
US20100291032A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF RETROVIRAL INFECTION

#3358
US20100291033A1
Chemistry; metallurgy

Albumin Fusion Proteins

#3359
US20100291034A1
Human necessities

COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO

#3360 ✅ Patent 9,107,939 granted on 2015-08-18
US20100291035A1
Human necessities

Respiratory syncytial virus with a genomic deficiency complemented in trans

#3361
US20100291036A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION

#3362
US20100291037A1
Chemistry; metallurgy

IMMUNOGENICITY USING A COMBINATION OF DNA AND VACCINIA VIRUS VECTOR VACCINES

#3363
US20100291038A1
Human necessities

Novel Medicinal Formulation for Inducing an Immune Response in Patients with Chronic and Recurring Infections

#3364 ✅ Patent 8,404,254 granted on 2013-03-26
US20100291039A1
Chemistry; metallurgy

Micro-organisms controlling plant pathogens

#3365 ✅ Patent 8,153,115 granted on 2012-04-10
US20100291040A1
Chemistry; metallurgy

Virus-like particles for treatment of viral infections

#3366
US20100291041A1
Human necessities

BACTERIOPHAGE PREPARATION AND USE

#3367
US20100291042A1
Human necessities

MULTIPOTENT STEM CELLS AND USES THEREOF

#3368 ✅ Patent 8,765,462 granted on 2014-07-01
US20100291043A1
Human necessities

IL-12 immunotherapy for cancer

#3369 ✅ Patent 9,678,060 granted on 2017-06-13
US20100291044A1
Physics

Lunasin-induced regulation of disease-related gene expression

#3370
US20100291045A1
Chemistry; metallurgy

DYNAMIC VIBRATIONAL METHOD AND DEVICE FOR VOCAL FOLD TISSUE GROWTH

#3371 ✅ Patent 10,655,103 granted on 2020-05-19
US20100291046A1
Chemistry; metallurgy

Equine progenitor cells

#3372
US20100291047A1
Human necessities

Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders

#3373 ✅ Patent 8,871,905 granted on 2014-10-28
US20100291048A1
Human necessities

Modification of CXCR4 using engineered zinc finger proteins

#3374 ✅ Patent 8,088,369 granted on 2012-01-03
US20100291049A1
Human necessities

Anti-wrinkle agent

#3375 ✅ Patent 8,257,694 granted on 2012-09-04
US20100291050A1
Human necessities

Nutritional compositions for reducing oxidative damage

#3376 ✅ Patent 8,747,836 granted on 2014-06-10
US20100291051A1
Chemistry; metallurgy

Agent for prevention of alcoholic hepatopathy

#3377 ✅ Patent 8,748,158 granted on 2014-06-10
US20100291052A1
Chemistry; metallurgy

Microorganism having gastric-juice promoting activity, and its secretory product

#3378
US20100291053A1
Human necessities

Inflammatory Disease Treatment

#3379
US20100291054A1
Chemistry; metallurgy

NOVEL REGULATORY T CELLS AND USES THEREOF

#3380
US20100291055A1
Human necessities

SURGICAL HYDROGEL

#3381 ✅ Patent 8,236,782 granted on 2012-08-07
US20100291056A1
Human necessities

Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same

#3382 ✅ Patent 9,511,141 granted on 2016-12-06
US20100291057A1
Human necessities

Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy

#3383
US20100291058A1
Human necessities

Sealants for Skin and Other Tissues

#3384 ✅ Patent 8,569,032 granted on 2013-10-29
US20100291059A1
Chemistry; metallurgy

Proteins having acquired A-galactosidase activity

#3385
US20100291060A1
Human necessities

SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

#3386 ✅ Patent 9,382,546 granted on 2016-07-05
US20100291061A1
Chemistry; metallurgy

Process for making oligopeptides

#3387 ✅ Patent 9,302,027 granted on 2016-04-05
US20100291062A1
Human necessities

Antimicrobial composition comprising pyrogenic silica and serratiopeptidase

#3388
US20100291063A1
Chemistry; metallurgy

PROTEASE INHIBITION

#3389 ✅ Patent 8,809,497 granted on 2014-08-19
US20100291064A1
Human necessities

Compounds and methods for the treatment of vascular disease

#3390
US20100291065A1
Human necessities

Compositions for Protein Delivery and Methods of Use Thereof

#3391
US20100291066A1
Chemistry; metallurgy

DONOR SPECIFIC ANTIBODY LIBRARIES

#3392 ✅ Patent 9,719,069 granted on 2017-08-01
US20100291067A1
Chemistry; metallurgy

Methods and compositions relating to viral latency

#3393
US20100291068A1
Chemistry; metallurgy

NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER

#3394 ✅ Patent 8,828,924 granted on 2014-09-09
US20100291069A1
Human necessities

Methods of treating a diabetic embryopathy

#3395
US20100291070A1
Chemistry; metallurgy

TYPE III SECRETION SYSTEM COMPONENT PROTEIN PA1698 OF PSEUDOMONAS AERUGINOSA

#3396
US20100291071A1
Physics

Antibody Specific Binding to A-Beta Oligomer and the Use

#3397
US20100291072A1
Chemistry; metallurgy

ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES

#3398
US20100291073A1
Chemistry; metallurgy

METHODS OF REDUCING EOSINOPHIL LEVELS

#3399
US20100291074A1
Human necessities

CYCLOPHILIN D-AMYLOID BETA INTERACTION POTENTIATES MITOCHONDRIAL DYSFUNCTION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE

#3400 ✅ Patent 8,609,101 granted on 2013-12-17
US20100291075A1
Chemistry; metallurgy

Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies

#3401 ✅ Patent 8,338,576 granted on 2012-12-25
US20100291076A1
Human necessities

Antibodies specific for DKK-1 and their uses

#3402 ✅ Patent 8,461,114 granted on 2013-06-11
US20100291077A1
Chemistry; metallurgy

Methods and compositions for modulating ErbB2 activity

#3403
US20100291078A1
Chemistry; metallurgy

Proteinaceous binding molecules comprising purification tags or inert variable domains

#3404 ✅ Patent 8,293,707 granted on 2012-10-23
US20100291079A1
Chemistry; metallurgy

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

#3405 ✅ Patent 8,889,140 granted on 2014-11-18
US20100291080A1
Human necessities

Compositions and methods for tissue repair

#3406 ✅ Patent 8,398,977 granted on 2013-03-19
US20100291081A1
Chemistry; metallurgy

Rage fusion proteins

#3407 ✅ Patent 8,518,410 granted on 2013-08-27
US20100291082A1
Chemistry; metallurgy

Fusion protein with HIV antigen

#3408 ✅ Patent 8,691,221 granted on 2014-04-08
US20100291083A1
Chemistry; metallurgy

Analgesic treatment with prolonged effect

#3409 ✅ Patent 8,586,035 granted on 2013-11-19
US20100291084A1
Chemistry; metallurgy

Use of IL-23 antagonists for treatment of infection

#3410 ✅ Patent 8,252,285 granted on 2012-08-28
US20100291085A1
Chemistry; metallurgy

Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses

#3411
US20100291086A1
Chemistry; metallurgy

USE OF ESTROGEN AND ANDROGEN BINDING PROTEINS IN METHODS AND COMPOSITIONS FOR TREATING GYNAECOLOGICAL CANCERS

#3412 ✅ Patent 8,298,534 granted on 2012-10-30
US20100291087A1
Human necessities

Method of treating fibrproliferative disorders

#3413 ✅ Patent 8,431,130 granted on 2013-04-30
US20100291088A1
Chemistry; metallurgy

IL-18 binding proteins

#3414
US20100291089A1
Human necessities

LIGAND OF REGULATING IMMUNE RESPONSE, AND USE THEREOF IN TREATING AN IMMUNE RESPONSE-RELATED DISEASE

#3415 ✅ Patent 9,217,036 granted on 2015-12-22
US20100291090A1
Chemistry; metallurgy

Prion protein as a receptor for amyloid-β oligomers

#3416
US20100291091A1
Physics

CANCER ASSOCIATED GENE LY6K

#3417 ✅ Patent 8,192,720 granted on 2012-06-05
US20100291092A1
Physics

Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases

#3418 ✅ Patent 9,394,371 granted on 2016-07-19
US20100291093A1
Human necessities

Antibody-mediated disruption of quorum sensing in bacteria

#3419 ✅ Patent 8,003,100 granted on 2011-08-23
US20100291094A1
Chemistry; metallurgy

Antibodies that bind to 238P1B2

#3420
US20100291095A1
Chemistry; metallurgy

IDENTIFICATION OF A CONSERVED REGION OF PLASMODIUM FALCIPARUM MSP3 TARGETED BY BIOLOGICALLY ACTIVE ANTIBODIES

#3421 ✅ Patent 8,093,208 granted on 2012-01-10
US20100291096A1
Chemistry; metallurgy

Therapeutic peptides for the treatment of metastatic cancer

#3422 ✅ Patent 9,403,902 granted on 2016-08-02
US20100291097A1
Chemistry; metallurgy

Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody

#3423 ✅ Patent 8,314,059 granted on 2012-11-20
US20100291098A1
Human necessities

Diabetic nephropathy therapies

#3424
US20100291099A1
Chemistry; metallurgy

NOVEL 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 AND 32222 MOLECULES AND USES THEREFOR

#3425
US20100291100A1
Chemistry; metallurgy

Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions

#3426 ✅ Patent 8,445,643 granted on 2013-05-21
US20100291101A1
Chemistry; metallurgy

Anti-IRC85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof

#3427
US20100291102A1
Human necessities

Therapeutic Agent

#3428 ✅ Patent 8,877,186 granted on 2014-11-04
US20100291103A1
Chemistry; metallurgy

Polypeptides, antibody variable domains and antagonists

#3429 ✅ Patent 8,877,201 granted on 2014-11-04
US20100291104A1
Human necessities

outer-membrane protein antigens and methods of making and using the same

#3430
US20100291105A1
Human necessities

AGENT FOR THE TREATMENT OF MALIGNANT DISEASES

#3431
US20100291106A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B

#3432 ✅ Patent 8,092,802 granted on 2012-01-10
US20100291107A1
Chemistry; metallurgy

High affinity human antibodies to human IL-4 receptor

#3433
US20100291108A1
Chemistry; metallurgy

ANTIBODIES TO IREM-1

#3434
US20100291109A1
Chemistry; metallurgy

TLR AGONIST (FLAGELLIN)/CD40 AGONIST/ANTIGEN PROTEIN AND DNA CONJUGATES AND USE THEREOF FOR INDUCING SYNERGISTIC ENHANCEMENT IN IMMUNITY

#3435 ✅ Patent 8,637,258 granted on 2014-01-28
US20100291110A1
Chemistry; metallurgy

Compositions and methods for regulating NK cell activity

#3436
US20100291111A1
Chemistry; metallurgy

Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation

#3437
US20100291112A1
Chemistry; metallurgy

Recombinant, Single-Chain, Trivalent Tri-Specific or Bi-Specific Antibody Derivatives

#3438
US20100291113A1
Human necessities

Treatment of Proliferative Disorders Using Antibodies to PSMA

#3439
US20100291114A1
Chemistry; metallurgy

Crystal structures and methods using same

#3440
US20100291115A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF

#3441
US20100291116A1
Human necessities

MICROPARTICLE COMPRISING CROSS-LINKED POLYMER

#3442
US20100291117A1
Chemistry; metallurgy

METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES

#3443
US20100291118A1
Chemistry; metallurgy

Class of Gamma Delta T Cells Activators and Use Thereof

#3444
US20100291119A9
Chemistry; metallurgy

Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis

#3445 ✅ Patent 9,085,641 granted on 2015-07-21
US20100291120A1
Chemistry; metallurgy

Peptides regulating the surface expression of the T cell receptor

#3446
US20100291121A1
Chemistry; metallurgy

Tumour-Specific Animal Proteins

#3447 ✅ Patent 8,106,015 granted on 2012-01-31
US20100291122A1
Human necessities

Method for enhancing immune response with peptide

#3448
US20100291123A1
Chemistry; metallurgy

T Cell Receptor CDR3 Sequences and Methods for Detection

#3449 ✅ Patent 8,216,794 granted on 2012-07-10
US20100291124A1
Chemistry; metallurgy

Extracellular serine protease

#3450 ✅ Patent 8,188,236 granted on 2012-05-29
US20100291125A1
Chemistry; metallurgy

Eta-1 gene and methods for use

#3451 ✅ Patent 8,236,510 granted on 2012-08-07
US20100291126A1
Physics

Protein showing enhanced expression in cancer cells

#3452 ✅ Patent 7,960,507 granted on 2011-06-14
US20100291127A1
Chemistry; metallurgy

Tumor associated antigen peptides and use of same as anti-tumor vaccines

#3453 ✅ Patent 9,119,810 granted on 2015-09-01
US20100291128A1
Human necessities

Compositions and vaccines against influenza A and influenza B infections

#3454 ✅ Patent 8,124,104 granted on 2012-02-28
US20100291129A1
Chemistry; metallurgy

Norovirus and sapovirus antigens

#3455
US20100291130A1
Physics

CLONED GENOME OF INFECTIOUS HEPATITIS C VIRUS STRAIN HC-TN AND USES THEREOF

#3456 ✅ Patent 8,263,088 granted on 2012-09-11
US20100291131A1
Chemistry; metallurgy

Clostridial toxin NetB

#3457 ✅ Patent 8,629,249 granted on 2014-01-14
US20100291132A1
Chemistry; metallurgy

adhesion molecule

#3458
US20100291133A1
Human necessities

RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1

#3459
US20100291134A1
Chemistry; metallurgy

TRUNCATED HEPATITIS C VIRUS NS5 DOMAIN AND FUSION PROTEINS COMPRISING SAME

#3460
US20100291135A1
Chemistry; metallurgy

Species of fungi and their use in pest and disease control

#3461 ✅ Patent 8,617,568 granted on 2013-12-31
US20100291136A1
Human necessities

Pharmaceutical liquid composition of botulinum toxin with improved stability

#3462
US20100291137A1
Human necessities

METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN

#3463
US20100291138A1
Human necessities

Vaccine

#3464 ✅ Patent 8,197,825 granted on 2012-06-12
US20100291139A1
Chemistry; metallurgy

Recombinant MVA virus and the use thereof

#3465 ✅ Patent 7,858,097 granted on 2010-12-28
US20100291140A1
Chemistry; metallurgy

Antibiotic resistance free strains and methods for constructing and using same

#3466 ✅ Patent 9,533,035 granted on 2017-01-03
US20100291141A1
Human necessities

Truncated L1 protein of human papillomavirus type 11

#3467
US20100291142A1
Human necessities

Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof

#3468
US20100291143A1
Human necessities

Inhibition of HIV and SHIV Replication with Antisense Interleukin-4

#3469 ✅ Patent 8,835,620 granted on 2014-09-16
US20100291144A1
Human necessities

Vaccines against multiple subtypes of dengue virus

#3470 ✅ Patent 8,815,249 granted on 2014-08-26
US20100291145A1
Human necessities

Ii-key/antigenic epitope hybrid peptide vaccines

#3471 ✅ Patent 8,999,353 granted on 2015-04-07
US20100291146A1
Human necessities

Method of eliciting an immune response against pandemic influenza virus

#3472 ✅ Patent 8,563,002 granted on 2013-10-22
US20100291147A1
Chemistry; metallurgy

Recombinant RSV antigens

#3473
US20100291148A1
Human necessities

Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens

#3474
US20100291149A1
Chemistry; metallurgy

ATTENUATED LISTERIA SPP. AND METHODS FOR USING THE SAME

#3475
US20100291150A1
Chemistry; metallurgy

PSEUDOMONAS EXOTOXIN A CD4+ T-CELL EPITOPES

#3476
US20100291151A1
Chemistry; metallurgy

1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR

#3477 ✅ Patent 8,883,172 granted on 2014-11-11
US20100291152A1
Human necessities

Chemically modified peptides with improved immunogenicity

#3478 ✅ Patent 9,296,995 granted on 2016-03-29
US20100291153A1
Chemistry; metallurgy

Vaccines against based on LPS glycosyltransferase mutants

#3479
US20100291154A1
Human necessities

COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE CORDYCEPS MYCELLIA EXTRACT AS AN ACTIVE INGREDIENT

#3480
US20100291155A1
Human necessities

ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION

#3481
US20100291156A1
Human necessities

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

#3482 ✅ Patent 8,197,871 granted on 2012-06-12
US20100291157A1
Human necessities

Composition for headache treatment

#3483
US20100291158A1
Human necessities

SUSTAINED RELEASE ORAL COMPOSITION OF AN ANTIPSYCHOTIC AGENT

#3484 ✅ Patent 8,388,983 granted on 2013-03-05
US20100291159A1
Human necessities

Film coatings containing fine particle size detackifiers and substrates coated therewith

#3485
US20100291160A1
Human necessities

PHARMACEUTICAL SYSTEM FOR TRANS-MEMBRANE DELIVERY

#3486 ✅ Patent 8,221,789 granted on 2012-07-17
US20100291161A1
Human necessities

Cellulose powder

#3487
US20100291162A1
Human necessities

ORAL COMPOSITIONS PROVIDING ENHANCED TOOTH STAIN REMOVAL

#3488
US20100291163A1
Human necessities

ORAL CARE COMPOSITION COMPRISING NANOPARTICULATE TITANIUM DIOXIDE

#3489 ✅ Patent 9,023,373 granted on 2015-05-05
US20100291164A1
Human necessities

Functionalized calcium phosphate hybrid systems for the remineralization of teeth and a method for producing the same

#3490
US20100291165A1
Human necessities

PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE HAVING A HYDROPHOBIC SURFACE-RESIDENT COATING

#3491
US20100291166A1
Chemistry; metallurgy

USE OF NITROGEN-DOPED TITANIUM OXIDE NANOPARTICLES AS AGENTS FOR PROTECTING AGAINST ULTRAVIOLET RADIATION

#3492
US20100291167A1
Performing operations; transporting

POROUS CARBON MATERIAL COMPOSITES AND THEIR PRODUCTION PROCESS, ADSORBENTS, COSMETICS, PURIFICATION AGENTS, AND COMPOSITE PHOTOCATALYST MATERIALS

#3493
US20100291168A1
Human necessities

ANTIMICROBIAL FORMULATIONS COMPRISING A COMBINATION OF A PYRIDINE THIOL AND A BIS-QUINOLINIUM SALT

#3494 ✅ Patent 8,545,862 granted on 2013-10-01
US20100291169A1
Human necessities

Polyelectrolyte complex for imparting antimicrobial properties to a substrate

#3495 ✅ Patent 8,017,580 granted on 2011-09-13
US20100291170A1
Human necessities

Therapies for chronic renal failure

#3496 ✅ Patent 8,512,752 granted on 2013-08-20
US20100291171A1
Human necessities

Hyaluronic acid derivatives obtained via “click chemistry” crosslinking

#3497 ✅ Patent 9,474,791 granted on 2016-10-25
US20100291172A1
Human necessities

Sterile autologous, allogenic or xenogenic implant and the method of its production

#3498
US20100291173A1
Human necessities

METHOD OF IMPROVING RENAL FUNCTION

#3499
US20100291174A1
Human necessities

BIOLOGICALLY ACTIVE DEVICE AND METHOD FOR ITS PRODUCTION

#3500 ✅ Patent 8,697,110 granted on 2014-04-15
US20100291175A1
Human necessities

Polymers comprising amorphous terpolymers and semicrystalline blocks

#3501 ✅ Patent 8,557,163 granted on 2013-10-15
US20100291176A1
Human necessities

Manufacturing three-dimensional scaffolds using cryogenic prototyping

#3502
US20100291177A1
Chemistry; metallurgy

PREVENTION OF STAPHYLOCOCCUS BIOFILM FORMATION

#3503 ✅ Patent 8,802,122 granted on 2014-08-12
US20100291178A1
Human necessities

Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue of bone

#3504
US20100291179A1
Human necessities

COMPOSITE BIOMATERIAL FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS

#3505
US20100291180A1
Human necessities

NERVE GUIDANCE TUBES

#3506
US20100291181A1
Human necessities

THERAPEUTIC DEVICES FOR PATTERNED CELL GROWTH

#3507
US20100291182A1
Human necessities

Drug-Loaded Fibers

#3508 ✅ Patent 8,647,645 granted on 2014-02-11
US20100291183A1
Human necessities

Enhanced moisture barrier immediate release film coating systems and substrates coated therewith

#3509
US20100291184A1
Human necessities

WOUND DRESSING WITH APERTURED COVER SHEET

#3510 ✅ Patent 8,236,784 granted on 2012-08-07
US20100291185A1
Chemistry; metallurgy

Composition comprising threitol phosphate and salts thereof

#3511 ✅ Patent 8,784,879 granted on 2014-07-22
US20100291186A1
Human necessities

Transdermal administration of tamsulosin

#3512 ✅ Patent 8,053,052 granted on 2011-11-08
US20100291187A1
Human necessities

Adhesive laminates for rapid wound occlusion

#3513
US20100291188A1
Human necessities

Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same

#3514 ✅ Patent 8,226,976 granted on 2012-07-24
US20100291189A1
Human necessities

Method of using cell-free protein synthesis to produce a membrane protein

#3515 ✅ Patent 8,911,774 granted on 2014-12-16
US20100291190A1
Human necessities

Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use

#3516 ✅ Patent 9,205,047 granted on 2015-12-08
US20100291191A1
Human necessities

Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix

#3517
US20100291192A1
Human necessities

Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria

#3518 ✅ Patent 8,945,544 granted on 2015-02-03
US20100291193A1
Performing operations; transporting

Immunogenic compositions comprising progastrin and uses thereof

#3519 ✅ Patent 7,994,309 granted on 2011-08-09
US20100291194A1
Chemistry; metallurgy

Compositions and methods for inhibiting expression of a mutant gene

#3520 ✅ Patent 8,603,519 granted on 2013-12-10
US20100291195A1
Human necessities

Topical delivery of L-arginine to cause beneficial effects

#3521
US20100291196A1
Human necessities

METHOD OF TREATMENT OF AUTISM SPECTRUM DISORDER WITH LIPOSOMAL REDUCED GLUTATHIONE

#3522
US20100291197A1
Human necessities

HOT MELT-FILLED SOFT CAPSULES

#3523 ✅ Patent 9,078,464 granted on 2015-07-14
US20100291198A1
Human necessities

Compositions of phytosterols with enhanced bioavailability

#3524
US20100291199A1
Chemistry; metallurgy

Compositions and Methods For The Treatment and Prevention of Disease

#3525
US20100291200A1
Human necessities

FORMULATIONS FOR POORLY SOLUBLE DRUGS

#3526
US20100291201A1
Human necessities

COATED PHARMACEUTICAL CAPSULE DOSAGE FORM

#3527 ✅ Patent 9,011,907 granted on 2015-04-21
US20100291202A1
Human necessities

Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release

#3528 ✅ Patent 8,105,631 granted on 2012-01-31
US20100291203A1
Human necessities

Opioid agonist/antagonist combinations

#3529
US20100291204A1
Human necessities

COMBINATION OF A LONG-ACTING HYPNOTIC AGENT AND A SHORT-ACTING HYPNOTIC AGENT AND THERAPEUTIC USE THEREOF

#3530
US20100291205A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MITIGATING RISK OF ALCOHOL INDUCED DOSE DUMPING OR DRUG ABUSE

#3531
US20100291206A1
Chemistry; metallurgy

ORAL DOSAGE FORM

#3532 ✅ Patent 8,858,994 granted on 2014-10-14
US20100291207A1
Human necessities

Pharmaceutical formulation comprising ezetimibe

#3533 ✅ Patent 8,703,193 granted on 2014-04-22
US20100291208A1
Human necessities

Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof

#3534
US20100291209A1
Human necessities

ORGANIC COMPOUNDS

#3535 ✅ Patent 8,916,682 granted on 2014-12-23
US20100291210A1
Chemistry; metallurgy

Lipid peptide and hydrogel

#3536
US20100291211A1
Human necessities

MATERIAL COMPOSITIONS WHICH COMPRISE ADULT STEM CELLS OBTAINED FROM EXOCRINE GLANDULAR TISSUE, IN PARTICULAR FOR USE IN REGENERATIVE MEDICINE, E.G. FOR RESTORING INJURED OR DAMAGED MYOCARDIAL TISSUE

#3537 ✅ Patent 8,084,426 granted on 2011-12-27
US20100291212A1
Human necessities

Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use

#3538 ✅ Patent 9,689,096 granted on 2017-06-27
US20100291213A1
Textiles; paper

Composite non-woven fibrous webs having continuous particulate phase and methods of making and using the same

#3539
US20100291214A1
Human necessities

THREE-DIMENSIONAL MICROFIBER EXTRUDATE STRUCTURE AND PROCESS FOR FORMING THREE-DIMENSIONAL MICROFIBER EXTRUDATE STRUCTURE

#3540 ✅ Patent 8,309,518 granted on 2012-11-13
US20100291215A1
Human necessities

Drug delivery matrices to enhance wound healing

#3541
US20100291216A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#3542
US20100291217A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#3543 ✅ Patent 8,586,555 granted on 2013-11-19
US20100291218A1
Human necessities

Immunomodulatory compositions, formulations, and methods for use thereof

#3544
US20100291219A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO PROGENITOR CELLS

#3545 ✅ Patent 8,138,157 granted on 2012-03-20
US20100291220A1
Human necessities

Antibiotic formulation and method of treatment

#3546
US20100291221A1
Human necessities

Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation

#3547 ✅ Patent 9,028,874 granted on 2015-05-12
US20100291222A1
Chemistry; metallurgy

Antioxidant nanosphere comprising [1,2]-dithiolane moieties

#3548
US20100291223A1
Human necessities

TREATMENT FOR DERMATOLOGICAL CONDITIONS

#3549
US20100291224A1
Physics

NANOSTRUCTURES, METHODS OF PREPARING AND USES THEREOF

#3550
US20100291225A1
Human necessities

Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same

#3551 ✅ Patent 9,161,906 granted on 2015-10-20
US20100291226A1
Human necessities

Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use

#3552
US20100291227A1
Human necessities

LIP LUBRICANT AND METHOD OF LUBRICATING THE LIPS

#3553
US20100291228A1
Human necessities

SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS

#3554
US20100291229A1
Human necessities

FUNGICIDAL COMPOSITIONS AND METHODS OF ENHANCING PLANTS SUCH AS TURFGRASS

#3555
US20100291230A1
Human necessities

Novel Pesticide Compositions

#3556
US20100291231A1
Human necessities

Compositions as Wound Sealant

#3557 ✅ Patent 9,445,590 granted on 2016-09-20
US20100291232A1
Human necessities

Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms

#3558
US20100291233A1
Human necessities

TREATMENT OF NEUROLOGICAL DISORDERS

#3559 ✅ Patent 10,092,595 granted on 2018-10-09
US20100291234A1
Human necessities

Compositions and methods for treating inflammatory arthritis

#3560
US20100291235A1
Human necessities

COMPOSITION FOR TREATING STERILE INFLAMMATION

#3561
US20100291236A1
Chemistry; metallurgy

OSMIUM COMPOUNDS

#3562 ✅ Patent 8,623,423 granted on 2014-01-07
US20100291237A1
Chemistry; metallurgy

Boron-containing compositions

#3563
US20100291238A1
Human necessities

Appetite suppressant product and method

#3564 ✅ Patent 8,377,487 granted on 2013-02-19
US20100291239A1
Human necessities

Mixture of citric flavonoids to improve ruminal fermentation

#3565 ✅ Patent 9,592,202 granted on 2017-03-14
US20100291240A1
Human necessities

Method to stabilize a dietary supplement to facilitate joint health in humans

#3566
US20100291241A1
Human necessities

METHOD OF PRODUCTION OF EXTRACT DERIVED FROM Swinglea Glutinosa LEAVES

#3567
US20100291242A1
Human necessities

ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS

#3568 ✅ Patent 8,916,210 granted on 2014-12-23
US20100291243A1
Human necessities

Extractor having pottery with a dark brown glaze and the method for extracting using thereof

#3569 ✅ Patent 8,541,035 granted on 2013-09-24
US20100291244A1
Human necessities

Methods for preparing a fermented ginseng concentrate or powder

#3570 ✅ Patent 9,155,772 granted on 2015-10-13
US20100291245A1
Human necessities

Soft, chewable and orally dissolvable and/or disintegrable products

#3571
US20100291246A1
Human necessities

Anti-infection P-compound™

#3572
US20100291247A1
Human necessities

OIL FORMULATIONS AND METHODS OF USE

#3573 ✅ Patent 9,381,222 granted on 2016-07-05
US20100291248A1
Human necessities

Compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of glycine max leaves or fractions isolated from the same as an active ingredient

#3574
US20100291249A1
Human necessities

Pomegranate-derived Products for the Treatment of Skin Sores and Lesions

#3575 ✅ Patent 8,277,850 granted on 2012-10-02
US20100291250A1
Human necessities

Use of an active ingredient that is obtained from for its anti-aging cutaneous action

#3576 ✅ Patent 10,701,957 granted on 2020-07-07
US20100291251A1
Human necessities

Method for production of carotenoid

#3577
US20100291252A1
Textiles; paper

Method of Producing Ultra Thin Chitosan Fibers and Non-Woven Fabrics

#3578 ✅ Patent 8,007,268 granted on 2011-08-30
US20100291253A1
Performing operations; transporting

Clamp assembly for clamping injection molding component

#3579 ✅ Patent 8,430,659 granted on 2013-04-30
US20100291254A1
Performing operations; transporting

Corrugator device with a gripper

#3580 ✅ Patent 8,500,432 granted on 2013-08-06
US20100291255A1
Performing operations; transporting

Corrugator device with a mould release device

#3581
US20100291256A1
Performing operations; transporting

MOLD FOR FABRICATING CONCAVE LENSES

#3582
US20100291257A1
Electricity

Template Having a Varying Thickness to Facilitate Expelling a Gas Positioned Between a Substrate and the Template

#3583 ✅ Patent 8,298,473 granted on 2012-10-30
US20100291258A1
Performing operations; transporting

Method of making a cure tool with integrated edge breather

#3584
US20100291259A1
Physics

INJECTION MOLD FOR MAKING WEDGE-SHAPED LIGHT GUIDE PLATE

#3585
US20100291260A1
Chemistry; metallurgy

USE OF CACAO POLYPHENOLS IN BEER PRODUCTION

#3586
US20100291261A1
Chemistry; metallurgy

CONTINUOUS BREWING PROCESS

#3587 ✅ Patent 8,679,774 granted on 2014-03-25
US20100291262A1
Human necessities

Lipolytic enzyme variants

#3588
US20100291263A1
Human necessities

METHOD OF PREPARING A LOW SODIUM FLOUR-BASED DOUGH WITH IMPROVED HANDLING PROPERTIES

#3589
US20100291264A1
Chemistry; metallurgy

NOVEL STRAIN IN NATTO-PRODUCING BACTERIA AND SOFT NATTO PRODUCED BY USING SAID STRAIN

#3590
US20100291265A1
Human necessities

BAKING COMPOSITION

#3591
US20100291266A1
Human necessities

Natural Sponge Food and Regimen

#3592
US20100291267A1
Human necessities

MEAT PRODUCTS WITH INCREASED LEVELS OF BENEFICIAL FATTY ACIDS

#3593
US20100291268A1
Human necessities

POPPED GRANULATED SNACKS

#3594 ✅ Patent 8,585,393 granted on 2013-11-19
US20100291269A1
Human necessities

Device for casting edible products

#3595 ✅ Patent 8,771,771 granted on 2014-07-08
US20100291270A1
Electricity

Food composition prepared by a sterilization process

#3596 ✅ Patent 8,475,858 granted on 2013-07-02
US20100291271A1
Human necessities

Methods for automatically making large quantities of pre-cooked eggs having a natural appearance

#3597 ✅ Patent 8,999,418 granted on 2015-04-07
US20100291272A1
Human necessities

Methods for reducing oil uptake of fried foods

#3598 ✅ Patent 8,968,810 granted on 2015-03-03
US20100291273A1
Human necessities

Mould and method for preparing a decorative cake coating

#3599 ✅ Patent 8,697,165 granted on 2014-04-15
US20100291274A1
Human necessities

Process for producing edible oil

#3600
US20100291275A1
Chemistry; metallurgy

Flavorant and Fragrance Furan-2(5H)-One Compounds